BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer Article

Kotsopoulos, Joanne, Willows, Karla, Trat, Sandra et al. (2018). BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer . International Journal of Gynecological Cancer, 28(1), 69-76. 10.1097/IGC.0000000000001144

International Collaboration

cited authors

  • Kotsopoulos, Joanne; Willows, Karla; Trat, Sandra; Kim, Raymond H; Volenik, Alexandra; Sun, Ping; Narod, Steven A; Boyd, Jeffrey; May, Taymaa

sustainable development goals

authors

publication date

  • January 1, 2018

published in

keywords

  • ALLELE
  • BRCA
  • BREAST-CANCER
  • CARRIERS
  • DAMAGE
  • DNA-REPAIR CAPACITY
  • FAMILY-HISTORY
  • GENOMIC INSTABILITY
  • HAPLOINSUFFICIENCY
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • Ovarian cancer
  • RADIOTHERAPY
  • SERIES
  • Science & Technology
  • Toxicity

Digital Object Identifier (DOI)

start page

  • 69

end page

  • 76

volume

  • 28

issue

  • 1